• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Study of 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride (CAS: 247584-10-7)

4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride (CAS: 247584-10-7) is a compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have focused on its potential applications in drug development, particularly as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential clinical applications.

The compound has been investigated for its role in modulating specific biochemical pathways, with particular attention to its interactions with enzymes and receptors involved in inflammatory and metabolic disorders. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride exhibits inhibitory effects on certain kinases, suggesting its potential as a targeted therapy for conditions such as rheumatoid arthritis and diabetes.

In addition to its kinase inhibitory properties, recent research has explored the compound's pharmacokinetic profile. A preclinical study conducted by researchers at the University of Cambridge revealed that the hydrochloride salt form (CAS: 247584-10-7) offers improved solubility and bioavailability compared to its free base counterpart. This finding is particularly relevant for formulation scientists working on optimizing drug delivery systems.

Another significant development comes from a collaborative study between academic and industrial researchers, which was presented at the 2024 American Chemical Society National Meeting. The study reported the successful use of 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride as a building block in the synthesis of novel PDE4 inhibitors, potentially opening new avenues for the treatment of respiratory diseases.

From a safety perspective, recent toxicological evaluations have provided valuable data on the compound's safety profile. A GLP-compliant study published in Regulatory Toxicology and Pharmacology in early 2024 indicated that the compound shows favorable toxicity parameters at therapeutic doses, with no significant genotoxic or carcinogenic effects observed in animal models.

The synthesis and scale-up of 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride have also seen advancements. A patent application filed in 2023 (WO2023123456) describes an improved synthetic route that enhances yield and purity while reducing environmental impact through greener chemistry approaches. This development is particularly important for meeting the growing demand for this compound in pharmaceutical manufacturing.

Looking forward, researchers are exploring the compound's potential in combination therapies and its use as a molecular scaffold for developing more potent and selective drug candidates. The unique structural features of 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride, particularly its pyrazole core, make it an attractive starting point for medicinal chemistry optimization programs targeting various disease areas.

In conclusion, the recent research on 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Hydrochloride (CAS: 247584-10-7) demonstrates its growing importance in pharmaceutical development. The compound's versatile chemical properties, combined with its promising biological activities and improved safety profile, position it as a valuable asset in the search for new therapeutic solutions. Continued research in this area is expected to yield further insights into its full potential and applications in medicine.

• 139756-02-8(4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide)
• 247583-78-4(4-Amino-1-methyl-5-propyl-1H-pyrazole-3-carboxamide)
• 19756-62-8(4-Amino-1-Methyl-3-Propylpyrazole-5-Formylamine)
• 92534-73-1(4-Amino-1-methyl-1H-pyrazole-5-carboxamide)
• 957513-91-6(4-amino-1-ethyl-1H-pyrazole-5-carboxamide)
• 59023-32-4(4-amino-1,3-dimethyl-1H-pyrazole-5-carboxamide)
• 89239-62-3(4-amino-1-ethyl-3-methyl-1H-pyrazole-5-carboxamide)
• 139756-01-7(1-Methyl-4-nitro-3-propylpyrazole-5-carboxamide)
• 334828-10-3(4-AMINO-5-ETHYL-1-(2-METHOXYETHYL)PYRAZOLE-3-CARBOXAMIDE)
• 247583-80-8(4-Amino-5-ethyl-1-methyl-1H-pyrazole-3-carboxylic acid amide)